首页> 外文期刊>Cellular Signalling >Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptors
【24h】

Characterization of dual agonists for kinin B1 and B2 receptors and their biased activation of B2 receptors

机译:激肽B1和B2受体双重激动剂的表征及其对B2受体的偏活化

获取原文
获取原文并翻译 | 示例
           

摘要

Kinin B1 and B2 receptors (kB1R and kB2R) play important roles in many physiological and pathological processes. In some cases, kB1R or kB2R activation can have overlapping or complementary beneficial effects, thus an activator of both receptors might be advantageous. We found that replacement of the C-terminal Arg in the natural kB2R activators bradykinin (BK) or kallidin (KD) with Lys (K ~9-BK or K ~(10)-KD) resulted in agonists that effectively stimulate the downstream signaling of both the kB1R and kB2R as measured by increased inositol turnover, intracellular calcium, ERK1/2 phosphorylation, arachidonic acid release and NO production. However, K ~9-BK and K ~(10)-KD displayed some characteristics of biased agonism for kB2Rs as indicated by the rapid kinetics of ERK1/2 phosphorylation induced by K ~9-BK or K ~(10)-KD compared with the prolonged response mediated by BK or KD. In contrast, kinetics of ERK phosphorylation stimulated by K ~(10)-KD activation of the kB1R was the same as that induced by known kB1R agonist des-Arg ~(10)-KD. Furthermore, the endocytosis of kB2Rs mediated by K ~9-BK and K ~(10)-KD was remarkably less than that induced by BK and KD respectively. K ~(10)-KD stimulated kB1R and kB2R-dependent calcium responses and ERK1/2 phosphorylation in bovine endothelial cells. In cytokine-treated human endothelial cells, K ~(10)-KD stimulated ERK1/2 phosphorylation and a transient peak of NO production that was primarily kB2R-dependent. K ~(10)-KD also stimulated prolonged NO production that was both kB1R and kB2R-dependent. These data provide the first examples of dual agonists of kB1R and kB2R, and a biased agonist of kB2R and may provide useful clues for developing dual modulators of kB1Rs and kB2Rs for potential therapeutic use.
机译:激肽B1和B2受体(kB1R和kB2R)在许多生理和病理过程中起重要作用。在某些情况下,kB1R或kB2R激活可能具有重叠或互补的有益作用,因此两种受体的激活剂可能是有利的。我们发现用Lys(K〜9-BK或K〜(10)-KD)替换天然kB2R激活剂缓激肽(BK)或激肽素(KD)中的C末端Arg会导致激动剂有效刺激下游信号传导通过增加的肌醇周转率,细胞内钙,ERK1 / 2磷酸化,花生四烯酸的释放和NO的产生来测量kB1R和kB2R的含量。然而,K〜9-BK和K〜(10)-KD对kB2Rs表现出一些偏向激动的特性,如K〜9-BK或K〜(10)-KD诱导的ERK1 / 2磷酸化的快速动力学所表明。由BK或KD介导的延长反应。相比之下,由kB1R的K〜(10)-KD激活刺激的ERK磷酸化动力学与已知的kB1R激动剂des-Arg〜(10)-KD诱导的动力学相同。此外,由K〜9-BK和K〜(10)-KD介导的kB2Rs的内吞作用明显小于由BK和KD诱导的内吞作用。 K〜(10)-KD刺激牛内皮细胞中的kB1R和kB2R依赖性钙反应和ERK1 / 2磷酸化。在细胞因子处理的人内皮细胞中,K〜(10)-KD刺激ERK1 / 2磷酸化和NO产生的瞬时峰值,主要是kB2R依赖性的。 K〜(10)-KD还刺激了kB1R和kB2R依赖性的延长的NO产生。这些数据提供了kB1R和kB2R双重激动剂以及kB2R偏置激动剂的第一个例子,并可能为开发潜在治疗用途的kB1R和kB2R双重调节剂提供有用的线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号